What is she best known for?
The fields of study she is best known for:
Her primary areas of study are Cancer research, Apoptosis, Survivin, Cancer cell and Cell culture.
Her Cancer research study integrates concerns from other disciplines, such as Cancer, Breast cancer, Prostate cancer, Cell and Immunology.
Her research integrates issues of Endocrinology, Melanoma, Cisplatin and In vivo in her study of Apoptosis.
Her Survivin research is multidisciplinary, incorporating perspectives in Cell growth, Inhibitor of apoptosis, Transfection, Kinase and Ribozyme.
Her Cell culture research focuses on subjects like Molecular biology, which are linked to Telomerase reverse transcriptase, Telomere and Telomerase.
The concepts of her Programmed cell death study are interwoven with issues in Autophagosome, MAP1LC3B, Sequestosome 1, Computational biology and Physiology.
Her most cited work include:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Guidelines for the use and interpretation of assays for monitoring autophagy (3242 citations)
- Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. (1531 citations)
What are the main themes of her work throughout her whole career to date?
Her scientific interests lie mostly in Cancer research, Internal medicine, Apoptosis, Oncology and Cell culture.
Her research integrates issues of Cancer cell, Cancer, Cisplatin, Cell growth and Immunology in her study of Cancer research.
Nadia Zaffaroni has researched Cancer cell in several fields, including Telomere, Telomerase and Cell biology.
Her Apoptosis research includes elements of Cell and In vivo.
She combines subjects such as Molecular biology, Cytotoxic T cell and Biochemistry with her study of Cell culture.
As part of one scientific family, Nadia Zaffaroni deals mainly with the area of Prostate cancer, narrowing it down to issues related to the microRNA, and often Bioinformatics and Metastasis.
She most often published in these fields:
- Cancer research (45.04%)
- Internal medicine (20.61%)
- Apoptosis (17.81%)
What were the highlights of her more recent work (between 2015-2021)?
- Cancer research (45.04%)
- Internal medicine (20.61%)
- Prostate cancer (12.98%)
In recent papers she was focusing on the following fields of study:
Nadia Zaffaroni mostly deals with Cancer research, Internal medicine, Prostate cancer, Oncology and Apoptosis.
Her work deals with themes such as Cancer cell, Cancer, MAPK/ERK pathway, Immunology and In vivo, which intersect with Cancer research.
Her Cancer cell study integrates concerns from other disciplines, such as Antigen, Telomere, Gene, Telomerase and Melanoma.
Within one scientific family, Nadia Zaffaroni focuses on topics pertaining to Cell culture under In vivo, and may sometimes address concerns connected to Pharmacology and Cytotoxic T cell.
Her study focuses on the intersection of Prostate cancer and fields such as microRNA with connections in the field of Bioinformatics, Transcription factor and Epithelial–mesenchymal transition.
The study incorporates disciplines such as Ovarian carcinoma, Moiety and Cisplatin in addition to Apoptosis.
Between 2015 and 2021, her most popular works were:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Armed Exosomes Deliver Proapoptotic Signals to Tumor Site (90 citations)
- miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis (60 citations)
In her most recent research, the most cited papers focused on:
Her primary scientific interests are in Cancer research, Apoptosis, Cancer cell, microRNA and Immunology.
Her Cancer research research incorporates elements of Downregulation and upregulation, Radioresistance, Signal transduction, Heparanase and Breast cancer.
Nadia Zaffaroni interconnects Cell culture, Cisplatin, Ovarian carcinoma, Moiety and Oxazole in the investigation of issues within Apoptosis.
Her Cancer cell research integrates issues from Bioinformatics, Metastasis, Innate immune system, Interleukin 10 and Immunotherapy.
Her work carried out in the field of microRNA brings together such families of science as Epithelial–mesenchymal transition, Cell growth, Transcription factor, TEP1 and Prostate cancer.
Her Immunology research is multidisciplinary, incorporating elements of Tumor progression and TLR9.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
